News

EBIO

IPO Report: Eleven Biotherapeutics (EBIO)

Francis Gaskins | Equities.com |

Eleven Biotherapeutics ($EBIO) is a clinical-stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it applies to the discovery and development of


12 IPOs Planned for February 3 Week

Francis Gaskins | Equities.com |

The full IPO calendar is available at IPOpremium.com Ranked by size of IPO, largest first. (1) Real estate finance Based in New York, NY, Ladder Capital ($LADR) scheduled a $225 million IPO on the


Sponsored Financial Content

Market Movers